References
1. Blackman AC, Staggers KA, Kronisch L, et al. Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy. Ann Allergy Asthma Immunol. 2020;125(2):196-201 e1.
2. Gradman J, Halken S. Preventive Effect of Allergen Immunotherapy on Asthma and New Sensitizations. J Allergy Clin Immunol Pract. 2021.
3. Shamji MH, Layhadi JA, Sharif H, et al. Immunological Responses and Biomarkers for Allergen-Specific Immunotherapy Against Inhaled Allergens. J Allergy Clin Immunol Pract. 2021.
4. Pfaar O, Agache I, Bonini M, et al. COVID-19 pandemic and allergen immunotherapy - an EAACI survey. Allergy. 2021.
5. Klimek L, Pfaar O, Worm M, et al. Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group(A) in cooperation with the Austrian ARIA Group(B), the Swiss ARIA Group(C), German Society for Applied Allergology (AEDA)(D), German Society for Allergology and Clinical Immunology (DGAKI)(E), Society for Pediatric Allergology (GPA)(F) in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHC(G) and the European Academy of Allergy and Clinical Immunology (EAACI)(H). Allergol Select. 2020;4:44-52.
6. Hettinga J, Carlisle R. Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects. Vaccines (Basel). 2020;8(3).
7. Bird JA, Sanchez-Borges M, Ansotegui IJ, et al. Skin as an immune organ and clinical applications of skin-based immunotherapy. World Allergy Organ J. 2018;11(1):38.
8. Wang J, Sampson HA. Safety and efficacy of epicutaneous immuntherapy for food allergy. Pediatr Allergy Immunol. 2018;29.
9. Scurlock AM, Burks AW, Sicherer SH, et al. Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research. J Allergy Clin Immunol. 2021;147(3):992-1003 e5.
10. Xiong L, Lin J, Luo Y, et al. The Efficacy and Safety of Epicutaneous Immunotherapy for Allergic Diseases: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol. 2020;181(3):170-182.
11. Chuang YY, Lin CS, Wang CH, et al. Distribution and seasonal occurrence of Forcipomyia taiwana (Diptera: Ceratopogonidae) in the Nantou area in Taiwan. J Med Entomol. 2000;37(2):205-209.
12. Chen YH, Lee MF, Lan JL, et al. Hypersensitivity to Forcipomyia taiwana (biting midge): clinical analysis and identification of major For t 1, For t 2 and For t 3 allergens. Allergy. 2005;60(12):1518-1523.
13. Chan KL, Saunders LG. Forcipomyia (Dacnoforcipomyia) Anabenae, a New Blood-Sucking Midge from Singapore, Described in All Stages (Diptera, Ceratopogonidae). Can J Zool. 1965;43:527-540.
14. Szadziewski R. [Forcipomyia (Lasiohelea) sibirica (Diptera, Ceratopogonidae) in Poland]. Wiad Parazytol. 1991;37(1):57-60.
15. Urbanek A, Richert M, Gilka W, et al. Morphology and histology of secretory setae in terrestrial larvae of biting midges of the genus Forcipomyia (Diptera: Ceratopogonidae). Arthropod Struct Dev. 2011;40(6):485-494.
16. Marino PI, Spinelli GR. Biting midges of the Forcipomyia (Forcipomyia) argenteola group in southern South America, with description of a new species and a key to the neotropical species (Diptera: Ceratopogonidae). Rev Biol Trop. 2008;56(2):789-794.
17. Huerta H, Spinelli GR. A distinctive new species of biting midge in the subgenus Euprojoannisia Brethes from Mexico with new records of Neotropical species of Forcipomyia Meigen (Diptera: Ceratopogonidae). Zootaxa. 2017;4329(2):189-195.
18. Chen YH, Hwang GY, Chen PC, et al. Molecular cloning and immunologic characterization of for t 2: a major allergen from the biting midgeForcipomyia taiwana . Allergy. 2011;66(5):703-705.
19. Chen YH, Lee MF, Tsai JJ, et al. Specific IgE and IgG responses and cytokine profile in subjects with allergic reactions to biting midgeForcipomyia taiwana . Int Arch Allergy Immunol. 2009;150(1):66-74.
20. Lee MF, Song PP, Lin TM, et al. For t 2 DNA vaccine preventsForcipomyia taiwana (biting midge) allergy in a mouse model. Allergy. 2016;71(4):522-531.
21. Lee MF, Chen YH, Song PP, et al. Therapeutic DNA vaccine attenuates itching and allergic inflammation in mice with established biting midge allergy. PLoS One. 2020;15(4):e0232042.
22. Lee MF, Yang KJ, Wang NM, et al. The development of a murine model for Forcipomyia taiwana (biting midge) allergy. PLoS One. 2014;9(3):e91871.
23. Trommer H, Neubert RH. Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol. 2006;19(2):106-121.
24. Wang Y, Kong Y, Wu MX. Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy. Front Immunol. 2021;12:647954.
25. Balmert SC, Carey CD, Falo GD, et al. Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination. J Control Release. 2020;317:336-346.
26. Erdos G, Balmert SC, Carey CD, et al. Improved Cutaneous Genetic Immunization by Microneedle Array Delivery of an Adjuvanted Adenovirus Vaccine. J Invest Dermatol. 2020;140(12):2528-31 e2.
27. Lademann J, Richter H, Schanzer S, et al. Follicular penetration of nanocarriers is an important penetration pathway for topically applied drugs. Hautarzt. 2019;70(3):185-192.
28. Ozturk AB, Baccioglu A, Soyer O, Civelek E, Sekerel BE, Bavbek S. Change in Allergy Practice during the COVID-19 Pandemic. Int Arch Allergy Immunol. 2021;182(1):49-52.